Mr.. Tonghe Zhu | Innovative Leadership | Young Scientist Award

Posted on by ScienceFather

Mr. Tonghe Zhu- Innovative Leadership -Young Scientist Award

Mr. Tonghe Zhu, Shanghai University of Engineering Science, China 

🔗 Professional Profiles

Summary

Dr. Tonghe Zhu is a renowned professor with extensive experience in biomaterials and tissue engineering. He specializes in the synthesis, fabrication, and characterization of bioactive materials for tissue regeneration, particularly using advanced manufacturing techniques like electrospinning and 3D printing.

Education 🎓

  • PhD in Biomaterials Science
    Donghua University, Shanghai, China
    2015.09-2018.09
  • ME in Textile Chemistry and Dyeing & Finishing Engineering
    Shanghai University of Engineering Science, Shanghai, China
    2012.09-2015.03
  • BS in Chemistry
    Hefei Normal University, Hefei, China
    2008.09-2012.07

Professional Experience 💼

  • Professor, Dean of Bio-additive Manufacturing Center
    Shanghai University of Engineering Science
    2023.12-present
  • Associate Professor, Dean of Bio-additive Manufacturing Center
    Shanghai University of Engineering Science
    2021.09-2023.12
  • Assistant Research Fellow
    Shanghai Jiao Tong University Affiliated Sixth People’s Hospital
    2021.03-2021.08
  • Postdoctoral Research Fellow
    Shanghai Jiao Tong University (Affiliated Sixth People’s Hospital)
    2019.01-2021.02

Research Interest 🔬

  • Bioactive Materials for Tissue Regeneration 🦠: Developing advanced materials to promote the healing of various tissues.
  • Synthetic Biomaterials 🧪: Creating innovative biomaterials for medical applications.
  • Electrospinning Nanofibers 🧵: Utilizing electrospinning technology to produce nanofibrous materials.
  • 3D Printing and Additive Manufacturing 🖨️: Leveraging 3D printing technologies to fabricate tissue engineering scaffolds.
  • Biodegradable Nanofibrous Materials ♻️: Designing materials for sustained delivery of active compounds in tissue regeneration.

Publication Top Noted

Fluffy Hybrid Nanoadjuvants for Reversing the Imbalance of Osteoclastic and Osteogenic Niches in Osteoporosis

    • Authors: Zhang, G., Kang, Y., Dong, J., … Wang, L., Yan, X.
    • Journal: Bioactive Materials
    • Volume: 39
    • Pages: 354-374
    • Year: 2024

Durable Immunomodulatory Hierarchical Patch for Rotator Cuff Repairing

    • Authors: Wang, L., Liu, Y., Lin, Z., … Zhang, Q., Zhao, J.
    • Journal: Bioactive Materials
    • Volume: 37
    • Pages: 477-492
    • Year: 2024

Biomimetic Design of Biomedical Scaffolds and Their Application in Tissue Engineering

    • Authors: Liang, C., Zhu, T., Zhu, Y., Li, R.
    • Journal: Chinese Journal of Tissue Engineering Research
    • Volume: 28
    • Issue: 15
    • Pages: 2416-2422
    • Year: 2024

Highly Bioadaptable Hybrid Conduits with Spatially Bidirectional Structure for Precision Nerve Fiber Regeneration via Gene Therapy

    • Authors: Zhao, R., Deng, X., Dong, J., … Zhu, T., Wang, G.
    • Journal: Advanced Science
    • Volume: 11
    • Issue: 19
    • Article Number: 2309306
    • Year: 2024

Self-Assembling Peptide Nanofibers Anchored Parathyroid Hormone Derivative for Bone Tissue Engineering

    • Authors: Hao, Z., Chen, T., Wang, Y., … Zhu, T., Li, J.
    • Journal: Advanced Fiber Materials
    • Volume: 6
    • Issue: 2
    • Pages: 583-606
    • Year: 2024

Prof Dr. Chi-Tai Yeh | Innovative Leadership | Excellence in Research | 2803

Posted on by ScienceFather

Prof Dr. Chi-Tai Yeh | Innovative Leadership | Excellence in Research

Prof Dr. Chi-Tai Yeh,Taipei Medical University-Shuang Ho Hospital,

 Professional Profile

Education 🎓

  • Post-Doctoral Fellow | Jan 2006 – Jan 2010
    National Institute of Cancer Research, Taiwan (R.O.C)
    National Health Research Institutes
  • Ph.D. in Food Science and Biotechnology | Aug 2001 – Aug 2005
    National Chung Hsing University, Taiwan (R.O.C)

Current Positions 📈

  • Professor | Apr 2021 – Present
    Continuing Education Program of Food Biotechnology Applications, College of Science and Engineering, National Taitung University, Taiwan (R.O.C)
  • Joint Appointment Research Fellow and Executive Secretary | Feb 2014 – Present
    Department of Research, Taipei Medical University – Shuang Ho Hospital, Taiwan (R.O.C)
  • Assistant Professor | Apr 2010 – Present
    Graduate Institute of Clinical Medicine, Taipei Medical University, Taiwan (R.O.C)

Professional Appointments and Experience 💼

  • Authored 91 articles in cancer and nutritional chemistry journals 📄
  • Contributed to 2 book chapters 📚
  • Secured 6 patents in cancer therapy compounds 🔬
  • Research Focus:
    • Cancer cell biology
    • Cancer stem cell studies
    • Nutrigenomics
    • Cancer prevention using dietary phytochemicals 🍎
  • Key Objectives:
    • Disrupt tumor growth and survival pathways
    • Enhance chemosensitivity and/or radiosensitivity
    • Develop methods to counter tumor metastasis
    • Test therapeutic interventions with tumor metastasis suppressor genes in preclinical trials
    • Employ high-throughput proteomic analysis to discover new tumor metastasis markers and evaluate therapeutic approaches

Notable Achievements 🏆

  • 5292 Citations 📈
  • h-Index: 42 🎖️
  • Developed new methods to counter tumor metastasis and enhance treatment efficacy in cancer therapy

Publication Top Noted:

  • Paper Title: PAICS/DYRK3 Multienzyme Interactions as Coregulators of Purinosome Formation and Metabolism on Radioresistance in Oral Squamous Cell Carcinoma
  • Paper Title: Tumor-Associated Macrophages Affect the Tumor Microenvironment and Radioresistance via the Upregulation of CXCL6/CXCR2 in Hepatocellular Carcinoma
  • Paper Title:  Furanocoumarin Notopterol: Inhibition of Hepatocellular Carcinogenesis through Suppression of Cancer Stemness Signaling and Induction of Oxidative Stress-Associated Cell Death
  • Paper Title: Correction: Chen et al. Hydroxychloroquine (HCQ) Modulates Autophagy and Oxidative DNA Damage Stress in Hepatocellular Carcinoma to Overcome Sorafenib Resistance via TLR9/SOD1/hsa-miR-30a-5p/Beclin-1 Axis. Cancers 2021, 13, 3227
  • Paper Title: Cancer-Associated Exosomal CBFB Facilitates the Aggressive Phenotype, Evasion of Oxidative Stress, and Preferential Predisposition to Bone Prometastatic Factor of Breast Cancer Progression